Eldorex Pharmaceuticals Private Limited
About Eldorex Pharmaceuticals Private Limited
Data last updated:
Eldorex Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 12 May 2023.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U21002MH2023PTC402869. Its GSTIN is 10AAHCE5623P1ZK (Bihar).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Puja Kumari and Kaveri Krishna.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Thane, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹25.2 Lakh, a growth of 149% compared to the previous year. For the same year it recorded a net profit of ₹8,716 (net margin 0.3%) and EBITDA of ₹48,368 (EBITDA margin 1.9%).
As per MCA filings, the company has open charges of ₹10 Lakh on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O S Kumar Jagdish, Prasad Manpada Ganesh Ngr, Thane, Maharashtra, India – 400603
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Eldorex Pharmaceuticals Private Limited
The main business activity of Eldorex Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Eldorex Pharmaceuticals Private Limited FY 2025 filings available
Eldorex Pharmaceuticals Private Limited reported revenue of ₹25.2 Lakh (up 149% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Eldorex Pharmaceuticals Private Limited
Revenue rose 149% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Eldorex Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | ₹48,368 | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | ₹8,716 | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Eldorex Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 1.9% | •••• |
| Net Profit Margin | 0.3% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Eldorex Pharmaceuticals are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Eldorex Pharmaceuticals Private Limited
Eldorex Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Adniv Pharmaceuticals Private Limited | ₹25.38 Lakh (FY 2025) | •••• | •••• | •••• | Assam, India | |
| Invipro Pharmaceuticals Private Limited | ₹25.37 Lakh (FY 2024) | •••• | •••• | 587.0% | •••• | Dehradun, Uttarakhand, India |
| Lorgov Pharmaceuticals Private Limited | ₹25.34 Lakh (FY 2025) | •••• | •••• | 69.0% | •••• | Hyderabad, Telangana, India |
| Linnea Pharmaceuticals (OPC) Private Limited | ₹25.31 Lakh (FY 2025) | •••• | •••• | 14.0% | •••• | Kopargaon, Maharashtra, India |
| Baiyoke Pharmaceuticals Private Limited | ₹25.25 Lakh (FY 2019) | •••• | •••• | 83.0% | •••• | Gwalior, Madhya Pradesh, India |
| Eldorex Pharmaceuticals Private Limited this company | ₹25.2 Lakh (FY 2025) | •••• | •••• | 149.0% | •••• | Thane, Maharashtra, India |
| Coix Pharmaceuticals Private Limited | ₹25.2 Lakh (FY 2024) | •••• | •••• | 93.0% | •••• | Jamshedpur, Jharkhand, India |
| Brukshell Drugs and Pharmaceuticals Private Limited | ₹25.16 Lakh (FY 2025) | •••• | •••• | 145.0% | •••• | Ahmedabad, Gujarat, India |
| Aayerah Pharmaceuticals Private Limited | ₹25.13 Lakh (FY 2025) | •••• | •••• | 8.0% | •••• | Bhubaneswar, Odisha, India |
| Anum Pharmaceuticals Private Limited | ₹25.13 Lakh (FY 2024) | •••• | •••• | -33.0% | •••• | Nagpur, Maharashtra, India |
| Dekunes Pharmaceuticals Private Limited | ₹25.05 Lakh (FY 2024) | •••• | •••• | 11.0% | •••• | Noida, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Eldorex Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Eldorex Pharmaceuticals Private Limited
Eldorex Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Puja Kumari | Director | 12 May 2023 | 3 Years 4 Months | Current |
| Kaveri Krishna | Director | 12 May 2023 | 3 Years 4 Months | Current |
Charges & Borrowings of Eldorex Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Sep 2024 | Others | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Eldorex Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Eldorex Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Eldorex Pharmaceuticals Private Limited
Eldorex Pharmaceuticals Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Kaveri Krishna was appointed as Director on 12 May 2023.
Credit Ratings, Litigation & Regulatory Alerts for Eldorex Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Eldorex Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Eldorex Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Eldorex Pharmaceuticals Private Limited
Eldorex Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAHCE5623P1ZK | Bihar | Active | 25 Jul 2023 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Eldorex Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Eldorex Pharmaceuticals Private Limited
Eldorex Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in paper and paper products, within the paper industry. It was incorporated on 12 May 2023 (3+ years old) and is registered under CIN U21002MH2023PTC402869.
Eldorex Pharmaceuticals reported revenue of ₹25.2 Lakh for FY 2025 (up 149% YoY).
Eldorex Pharmaceuticals has 2 current directors:
- Puja Kumari - Director
- Kaveri Krishna - Director
Eldorex Pharmaceuticals reported a net profit of ₹8,716 (net margin 0.3%) and EBITDA of ₹48,368 (EBITDA margin 1.9%) for FY 2025, as per its filed financial statements.
The GSTIN of Eldorex Pharmaceuticals is 10AAHCE5623P1ZK, registered in Bihar.
The CIN (Corporate Identification Number) of Eldorex Pharmaceuticals is U21002MH2023PTC402869. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eldorex Pharmaceuticals was incorporated on 12 May 2023, making it 3+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Eldorex Pharmaceuticals by revenue are Adniv Pharmaceuticals Private Limited, Invipro Pharmaceuticals Private Limited, Lorgov Pharmaceuticals Private Limited, Linnea Pharmaceuticals (OPC) Private Limited, Baiyoke Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Kaveri Krishna was appointed as Director on 12 May 2023. Puja Kumari was appointed as Director on 12 May 2023.
The registered office of Eldorex Pharmaceuticals is at CO S Kumar Jagdish, Prasad Manpada Ganesh Ngr, Thane, Maharashtra, India – 400603.
Eldorex Pharmaceuticals has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.